Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) development o...

Daiichi pays out Merck $170M to create bronchi cancer T-cell engager pact

.Merck &amp Co. has swiftly made back some of the expenses of its Weapon Therapeutics purchase, draw...

BioMarin standstills preclinical gene treatment for heart condition

.After BioMarin administered a spring tidy of its pipeline in April, the company has actually decide...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks work

.Significant Pharmas stay caught to the concept of molecular adhesive degraders. The most recent fir...

Life science credit history organization introduces with $600M

.A new worldwide life science credit rating organization, dubbed Symbiotic Capital, has actually inc...

BMS channels TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing an additional large bet from the Caforio time, terminating a package ...

Nuvation standstills BET inhibitor after thinking about phase 1 record

.After taking a look at period 1 information, Nuvation Biography has decided to halt focus on its ow...

' Medical instinct' led FDA consultants to back Zevra's uncommon health condition med

.Zevra Rehabs' uncommon disease drug seems to be on the path to permission this loss after gaining t...

Pfizer takes $230M reached after axing stopped working DMD gene therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failure has actually blown a $23...

AC Immune views 'landmark' possible in Alzheimer's medicine records

.After much more than twenty years of service neurodegenerative illness, Swiss biotech hvac Immune s...